Amount Raised
$20.4 Million
Round Type
Post-IPO Equity
TorontoBiotechnologyDescription
ProMIS Neurosciences Inc. (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that it closed its previously announced private investment in public equity (“PIPE”) financing, for the issuance and sale of common share units, each consisting of one of the Company’s common shares (the “Common Shares”) and one warrant to purchase one Common Share (the “Warrants”) (the “Common Share Units”) and pre-funded units, each consisting of one pre-funded warrant to purchase one Common Share and one Warrant. The Common Share Units were sold at a price of $1.88 per unit and the Pre-Funded Warrants were sold at a price of $1.87 per unit for gross proceeds of approximately $20.4 million, before deducting fees to the placement agents and other offering expenses payable by the Company.
Quick answer
ProMIS Neurosciences raised $20.4 Million in a Post-IPO Equity round, dated September 8, 2023. ProMIS Neurosciences is based in Toronto, Ontario, Canada.
- How much did ProMIS Neurosciences raise?
- ProMIS Neurosciences raised $20.4 Million in a Post-IPO Equity round on September 8, 2023.
- What does ProMIS Neurosciences do?
- ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of..
- Where is ProMIS Neurosciences based and how big is it?
- ProMIS Neurosciences is based in Toronto, Ontario, Canada. Fundz records about 26 employees.
- Who are the decision-makers at ProMIS Neurosciences?
- Fundz holds 1 contact at ProMIS Neurosciences, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as ProMIS Neurosciences that raised within 45 days of this round, from Fundz verified event records.
- Matter Bio raised an undisclosed amount (Funding Round) on October 23, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- VitaTek raised an undisclosed amount (Series A) on October 22, 2023.
- INNOCAN PHARMA Corp raised an undisclosed amount (Funding Round) on October 20, 2023.
- Stramsen BiotechInc raised $10M (Series F) on October 20, 2023.
- Amatera raised $1.6M (Seed) on October 20, 2023.
Who to call at ProMIS Neurosciences, and when
A new round usually means ProMIS Neurosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ProMIS Neurosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ProMIS Neurosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ProMIS Neurosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ProMIS Neurosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ProMIS Neurosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.